Memory-like differentiation enhances NK cell responses against colorectal cancer

References

• Rawla P, Sunkara T, Barsouk A. Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors. Przegla̜d Gastroenterol. 2019;14(2):89. doi:10.5114/pg.2018.81072.
   PubMed Web of Science ®Google Scholar
• American Cancer Society Inc. Cancer-Facts-and-Figures-2023. 2023.
   Google Scholar
• Lin A, Zhang J, Luo P. Crosstalk between the MSI status and tumor microenvironment in colorectal cancer. Front Immunol. 2020 Aug 12;11. doi:10.3389/fimmu.2020.02039.
   Web of Science ®Google Scholar
• Biller LH, Schrag D. Diagnosis and treatment of metastatic colorectal cancer: a review. JAMA. 2021 Feb 16;325(7):669–11. doi:10.1001/jama.2021.0106.
   PubMed Web of Science ®Google Scholar
• Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S. Functions of natural killer cells. Nat Immunol. 2008 May 18;9(5):503–510. doi:10.1038/ni1582.
   PubMed Web of Science ®Google Scholar
• Lanier LL. NK cell receptors. Annu Rev Immunol. 1998;16(1):359–393. doi:10.1146/annurev.immunol.16.1.359.
   PubMedGoogle Scholar
• Mittal D, Gubin MM, Schreiber RD, Smyth MJ. New insights into cancer immunoediting and its three component phases – elimination, equilibrium and escape. Curr Opin Immunol. 2014 Apr;27(1):16–25. doi:10.1016/j.coi.2014.01.004.
   PubMedGoogle Scholar
• Rocca YS, Roberti MP, Juliá EP, Pampena MB, Bruno L, Rivero S, Huertas E, Sánchez Loria F, Pairola A, Caignard A. et al. Phenotypic and functional dysregulated blood NK cells in colorectal cancer patients can be activated by cetuximab plus IL-2 or IL-15. Front Immunol. 2016 Oct 10;7(OCT):413. doi:10.3389/fimmu.2016.00413.
   PubMedGoogle Scholar
• Coca S, Perez-Piqueras J, Martinez D, Colmenajero A, Saez MA, Vallejo C, Martos JA. The prognostic significance of intratumoral natural killer cells in patients with colorectal carcinoma BACKGROUND. Natural killer (NK) cells have a spontaneous cytotoxic capacity. Cancer. 1997;79(12):2320–2328. doi:10.1002/(SICI)1097-0142(19970615)79:12<2320:AID-CNCR5>3.0.CO;2-P.
   PubMed Web of Science ®Google Scholar
• Tang YP, Xie MZ, Li KZ, Li JL, Cai ZM, Hu BL. Prognostic value of peripheral blood natural killer cells in colorectal cancer. BMC Gastroenterol. 2020 Feb 7;20(1). doi:10.1186/s12876-020-1177-8.
   Web of Science ®Google Scholar
• Imai K, Matsuyama S, Miyake S, Suga K, Yu H, Nakachi K. Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population. Lancet. 2000 Nov 25;356(9244):1795–1799. doi:10.1016/S0140-6736(00)03231-1.
   PubMed Web of Science ®Google Scholar
• Rocca YS, Roberti MP, Arriaga JM, Amat M, Bruno L, Pampena MB, Huertas E, Loria FS, Pairola A, Bianchini M. et al. Altered phenotype in peripheral blood and tumor-associated NK cells from colorectal cancer patients. Innate Immun. 2013 Feb;19(1):76–85. doi:10.1177/1753425912453187.
   PubMed Web of Science ®Google Scholar
• Romee R, Rosario M, Berrien-Elliott MM, Wagner JA, Jewell BA, Schappe T, Leong JW, Abdel-Latif S, Schneider SE, Willey S. et al. Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia. Sci Transl Med. 2016 Sep 21;8(357):357ra123. doi:10.1126/scitranslmed.aaf2341.
   PubMed Web of Science ®Google Scholar
• Marin ND, Krasnick BA, Becker-Hapak M, Conant L, Goedegebuure SP, Berrien-Elliott MM, Robbins KJ, Foltz JA, Foster M, Wong P. et al. Memory-like differentiation enhances NK cell responses to melanoma. Clin Cancer Res. 2021 Sep 1;27(17):4859–4869. doi:10.1158/1078-0432.CCR-21-0851.
   PubMed Web of Science ®Google Scholar
• Jacobs MT, Wong P, Zhou AY, Becker-Hapak M, Marin ND, Marsala L, Foster M, Foltz JA, Cubitt CC, Tran J, et a. Memory-like differentiation, tumor-targeting mAbs, and chimeric antigen receptors enhance natural killer cell responses to head and neck cancer. Clin Cancer Res. Aug 9;2023;29(20): 4196–4208. doi:10.1158/1078-0432.CCR-23-0156.
   PubMed Web of Science ®Google Scholar
• Ni J, Miller M, Stojanovic A, Garbi N, Cerwenka A. Sustained effector function of IL-12/15/18–preactivated NK cells against established tumors. J Exp Med. 2012/12/05 ed. 2012 Dec 17;209(13):2351–2365. doi:10.1084/jem.20120944.
   PubMed Web of Science ®Google Scholar
• Della Chiesa M, Setti C, Giordano C, Obino V, Greppi M, Pesce S, Marcenaro E, Rutigliani M, Provinciali N, Paleari L. et al. NK cell-based immunotherapy in colorectal cancer. Nato Adv Sci Inst Se. 2022;10(7):1033. doi: 10.3390/vaccines10071033.
   Google Scholar
• VanDussen KL, Marinshaw JM, Shaikh N, Miyoshi H, Moon C, Tarr PI, Ciorba MA, Stappenbeck TS. Development of an enhanced human gastrointestinal epithelial culture system to facilitate patient-based assays. Gut. 2015 Jun 1;64(6):911–920. doi:10.1136/gutjnl-2013-306651.
   PubMed Web of Science ®Google Scholar
• Vandussen KL, Sonnek NM, Stappenbeck TS. L-WRN conditioned medium for gastrointestinal epithelial stem cell culture shows replicable batch-to-batch activity levels across multiple research teams. Stem Cell Res. 2019;37(101430):101430. doi:10.1016/j.scr.2019.101430.
   PubMedGoogle Scholar
• Becker-Hapak MK, Shrestha N, McClain E, Dee MJ, Chaturvedi P, Leclerc GM, Marsala LI, Foster M, Schappe T, Tran J. et al. A fusion protein complex that combines IL-12, IL-15, and IL-18 signaling to induce memory-like NK cells for cancer immunotherapy. Cancer Immunol Res. 2021 Sep 1;9(9):1071–1087. doi:10.1158/2326-6066.CIR-20-1002.
   PubMed Web of Science ®Google Scholar
• Gang M, Marin NDD, Wong P, Neal CCC, Marsala L, Foster M, Schappe T, Meng W, Tran J, Schaettler M. et al. CAR-modified memory-like NK cells exhibit potent responses to NK-resistant lymphomas. Blood. 2020 Nov 12;136(20):2308–2318. doi:10.1182/blood.2020006619.
   PubMed Web of Science ®Google Scholar
• Bednarski JJ, Zimmerman C, Berrien-Elliott MM, Foltz JA, Becker-Hapak M, Neal CC, Foster M, Schappe T, McClain E, Pence PP. et al. Donor memory-like NK cells persist and induce remissions in pediatric patients with relapsed AML after transplant. Blood. 2021/12/07 ed. 2022 Mar 17;139(11):1670–1683. doi:10.1182/blood.2021013972.
   PubMed Web of Science ®Google Scholar
• Berrien-Elliott MM, Foltz JA, Russler-Germain DA, Neal CC, Tran J, Gang M, Wong P, Fisk B, Cubitt CC, Marin ND. et al. Hematopoietic cell transplantation donor-derived memory-like NK cells functionally persist after transfer into patients with leukemia. Sci Transl Med. 2022 Feb 23;14(633):eabm1375. doi:10.1126/scitranslmed.abm1375.
   PubMed Web of Science ®Google Scholar
• Uppendahl LD, Felices M, Bendzick L, Ryan C, Kodal B, Hinderlie P, Boylan KLM, Skubitz APN, Miller JS, Geller MA. Cytokine-induced memory-like natural killer cells have enhanced function, proliferation, and in vivo expansion against ovarian cancer cells. Gynecol Oncol. 2019/01/20 ed. 2019 Apr 1;153(1):149–157. doi:10.1016/j.ygyno.2019.01.006.
   PubMed Web of Science ®Google Scholar
• Poggi A, Villa F, Fernadez JLC, Costa D, Zocchi MR, Benelli R. Three-dimensional culture models to study innate anti-tumor immune response: advantages and disadvantages. Cancers. 2021 Jul 2;13(14):3417. doi:10.3390/cancers13143417.
   PubMed Web of Science ®Google Scholar
• Dean L, Kane M. 2020. Cetuximab therapy and RAS and BRAF genotype. In: Pratt VM, Scott SA, Pirmohamed M, Esquivel B, Kattman BL, Malheiro AJ, editors. Medical Genetics Summaries [Internet]. Bethesda (MD): National Center for Biotechnology Information (US) 2012. Nov 24.
   Google Scholar
• Sargenti A, Musmeci F, Bacchi F, Delprete C, Cristaldi DA, Cannas F, Bonetti S, Pasqua S, Gazzola D, Costa D. et al. Physical characterization of colorectal cancer spheroids and evaluation of NK cell infiltration through a flow-based analysis. Front Immunol. 2020;11(December):1–13. doi: 10.3389/fimmu.2020.564887.
   PubMedGoogle Scholar
• Lanuza PM, Vigueras A, Olivan S, Prats AC, Costas S, Llamazares G, Sanchez-Martinez D, Ayuso JM, Fernandez L, Ochoa I. et al. Activated human primary NK cells efficiently kill colorectal cancer cells in 3D spheroid cultures irrespectively of the level of PD-L1 expression. OncoImmunology. 2018 Apr 3;7(4). doi:10.1080/2162402X.2017.1395123.
   PubMed Web of Science ®Google Scholar
• Lanuza PM, Alonso MH, Hidalgo S, Uranga-Murillo I, García-Mulero S, Arnau R, Santos C, Sanjuan X, Santiago L, Comas L. et al. Adoptive NK cell transfer as a treatment in colorectal cancer patients: analyses of tumour cell determinants correlating with efficacy in vitro and in vivo. Front Immunol. 2022 Jun 7;13. DOI:10.3389/fimmu.2022.890836.
   PubMed Web of Science ®Google Scholar
• Otegbeye F, Ojo E, Moreton S, Mackowski N, Lee DA, De Lima M, Wald DN. Inhibiting TGF-beta signaling preserves the function of highly activated, in vitro expanded natural killer cells in AML and colon cancer models. PloS One. 2018 Jan 1;13(1):e0191358. doi:10.1371/journal.pone.0191358.
   PubMed Web of Science ®Google Scholar
• Sconocchia G, Eppenberger S, Spagnoli GC, Tornillo L, Droeser R, Caratelli S, Ferrelli F, Coppola A, Arriga R, Lauro D. et al. NK cells and T cells cooperate during the clinical course of colorectal cancer. OncoImmunology. 2014;3(8):1–6. doi: 10.4161/21624011.2014.952197.
   Web of Science ®Google Scholar
• Veluchamy JP, Spanholtz J, Tordoir M, Thijssen VL, Heideman DAM, Verheul HMW, de Gruijl TD, van der Vliet HJ. Combination of NK cells and cetuximab to enhance anti-tumor responses in RAS mutant metastatic colorectal cancer. PloS One. 2016 Jun 1;11(6):e0157830. doi:10.1371/journal.pone.0157830.
   PubMed Web of Science ®Google Scholar
• Ishikawa T, Okayama T, Sakamoto N, Ideno M, Oka K, Enoki T, Mineno J, Yoshida N, Katada K, Kamada K. et al. Phase I clinical trial of adoptive transfer of expanded natural killer cells in combination with IgG1 antibody in patients with gastric or colorectal cancer. Int J Cancer. 2018;142(12):2599–2609. doi: 10.1002/ijc.31285.
   PubMed Web of Science ®Google Scholar
• Otegbeye F, Cooper B, Caimi P, Zamborsky K, Reese-Koc J, Hillian A, Hernandez-Collazo Y, Lee G, Boughan K, Tomlinson B. et al. A phase I study to determine the maximum tolerated dose of ex vivo expanded natural killer cells derived from unrelated, HLA-Disparate adult donors. Transplant Cell Ther. 2022 May 1;28(5):.e250.1–.e250.8. doi:10.1016/j.jtct.2022.02.008.
   Google Scholar
• Berrien-Elliott MM, Cashen AF, Cubitt CC, Neal CC, Wong P, Wagner JA, Foster M, Schappe T, Desai S, McClain E. et al. Multidimensional analyses of donor memory-like NK cells reveal new associations with response after adoptive immunotherapy for leukemia. Cancer Discov. 2020 Dec 21;10(12):1854–1871. doi:10.1158/2159-8290.CD-20-0312.
   PubMed Web of Science ®Google Scholar